The methods and controls used for ancillary material manufacturing conform with cGMP for medical devices, 21 CFR Part 820 and USP, Ph Eur 5.2.12. CTS products aim to reduce the time you spend from your initial discovery to approved therapy.
#Not a valid boxstructure texmacs pro
Ongoing efforts in innovation allow us to offer media specific for the growth and expansion of human T-lymphocytes, for example, CTS OpTmizer Pro Serum Free Medium (SFM) for use in allogeneic cell therapies. We offer tailored T-cell media, dendritic cell culture media, and supplements for a variety of immune cell types.
Our CTS T-cell culture media and reagents help minimize the risk of contamination and variability in your research and provide extensive traceability documentation, including FDA Drug Master Files and/or Regulatory Support Files to support regulatory review, thus facilitating a seamless transition from research to commercialization. Products for a smoother transition from research to clinic Whether you’re developing a CAR-T therapy, another type of T-cell immunotherapy, or working with other immune cell types, Gibco CTS products are the superior choice from research to clinic, and beyond.Ĭell Therapy Systems (CTS) tools, reagents, and services, support cell therapy research and further manufacturing of cell-, gene-, and tissue-based products.
0 kommentar(er)
